Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older who are willing and able to give their informed consent to participate.
- People who have been diagnosed with prostate cancer that has spread to other parts of the body (metastatic prostate cancer).
- People whose doctor has planned for them to start a treatment called 177Lu-PSMA (also known as Pluvicto).
- People who are able to undergo two specialised imaging scans (called PET/CT scans using 68Ga-PSMA or 18F-DCFPyL) — one before treatment begins and one after 12 weeks of treatment.
- People with a general health and activity level rated as 0, 1, or 2 on a standard medical scale (ECOG), meaning they are able to carry out at least some daily activities with little to moderate limitation (confirm with trial site).
Who may not be able to join:
- People who have another illness, infection, or health condition that would prevent them from fully taking part in the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 608-268-9684
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Investigate intent to change treatment decisions after the addition of the TRAQinform Theranostics
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.